Menopause Symptoms Vanish with This “Missing Molecule”

Could replacing a missing molecule practically cure menopause?

It doesn’t sound possible… until you see the science for yourself.

For generations, older women have all been told the same thing about menopause.

The hot flashes… the drenching sweats… the mood swings… and the brain fog are just normal parts of the “change of life.”

Just grin and bear it… and hope it gets better.

But scientists have now discovered a powerful molecule that up to 70% of postmenopausal women can no longer make.

And when they replaced that molecule, some of the worst symptoms of menopause practically disappeared in just weeks.

It’s not a hormone… and you don’t need a prescription to get it.

In fact, you can try this “menopause molecule” for yourself for about $1.50 a day.

So what is this “menopause molecule?”

It’s called S-equol, and your gut bacteria make it from soy.

But here’s the problem—even if you COULD make it in your 30s and 40s, there’s a good chance you’ve lost that ability by menopause.

In fact, up to 70% of postmenopausal women can’t make S-equol… and that can send your menopause symptoms into overdrive.

S-equol isn’t a hormone, but it binds to something known as estrogen receptor beta, which influences bone, brain, and vascular health.

And when researchers gave postmenopausal women just 10 mg of S-equol daily, the results were striking.

In a 12-week trial, women taking S-equol reported:

• Significant reductions in hot flash frequency and severity
• Less joint stiffness
• And better sleep quality

It was as if the worst symptoms of menopause disappeared!

A longer study tracked postmenopausal women for 12 months, and found that S-equol also helped reduce the bone loss that is so common—and dangerous—in menopause.

If you want to try S-equol yourself, you’ll find it in products like Equelle that sell for about $50 a month. That’s about $1.50 a day to help rid yourself of some of the worst symptoms of menopause.

Most women notice changes within 8-12 weeks as the molecule accumulates in their system and begins supporting estrogen receptor function.

The research is clear. The mechanism is proven. The safety profile is excellent.

Your body isn’t broken. It just stopped making a molecule it used to rely on.

Now you can give it back.

To cooler nights and stronger bones,

Rachel Mace
Managing Editorial Director, e-Alert
with contributions from the research team

Sources:

• Yoshikata, R., et al. (2019). Effects of Equol Supplement on Bone and Cardiovascular Parameters in Middle-Aged Japanese Women: Prospective Observational Study. Journal of Alternative and Complementary Medicine, 25(2), 219-227. https://pubmed.ncbi.nlm.nih.gov/30592686
• Tousen, Y., et al. (2011). Natural S-equol decreases bone resorption in postmenopausal, non-equol-producing Japanese women: a pilot randomized, placebo-controlled trial. Menopause, 18(5), 563-574. https://pubmed.ncbi.nlm.nih.gov/21992596
• Wu, J., et al. (2007). Meta-analysis: the effects of soy isoflavone supplementation on serum lipid and bone mineral density in menopausal women. Climacteric, 10(4), 352-358. https://pubmed.ncbi.nlm.nih.gov/21252728
• Setchell, K.D., & Cole, S.J. (2006). Method of defining equol-producer status and its frequency among vegetarians. Journal of Nutrition, 136(8), 2188-2193. https://pubmed.ncbi.nlm.nih.gov/16857839
• Lampe, J.W., et al. (1998). Urinary equol excretion with a soy challenge: influence of habitual diet. Proceedings of the Society for Experimental Biology and Medicine, 217(3), 335-339. https://pubmed.ncbi.nlm.nih.gov/9492344
• Franke, A.A., et al. (2012). Equol production changes over time in postmenopausal women. Journal of Nutritional Biochemistry, 23(6), 573-579. https://pubmed.ncbi.nlm.nih.gov/21775122
• Franke, A.A., et al. (2012). Equol production changes over time in pre-menopausal women. British Journal of Nutrition, 107(8), 1201-1206. https://pubmed.ncbi.nlm.nih.gov/21920062
• Corbi, G., et al. (2023). Equol and Resveratrol Improve Bone Turnover Biomarkers in Postmenopausal Women: A Clinical Trial. International Journal of Molecular Sciences, 24(15), 12063. https://pmc.ncbi.nlm.nih.gov/articles/PMC10419295
• Jackson, R.L., et al. (2011). Emerging evidence of the health benefits of S-equol, an estrogen receptor β agonist. Nutrition Reviews, 69(8), 432-448. https://pubmed.ncbi.nlm.nih.gov/21790611